Across TCGA pan-cancer cohorts, MIR133B RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of MIR133B’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where MIR133B RNA is repressed in tumor relative to normal tissue. In most cancer types MIR133B is over-expressed in tumor, although a few such as KIRC and HNSC show the opposite, repressed pattern.

KIRC and HNSC are the cancer types where MIR133B tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR133B RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	II,III,IV	−0.104	.001	9	view →
HNSC	Male	IV	−0.618	.048	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: MIR133B RNA expression & survival · all MIR133B data types